Cite
Touloupas C, Faron M, Hadoux J, et al. Long Term Efficacy and Assessment of Tumor Response of Transarterial Chemoembolization in Neuroendocrine Liver Metastases: A 15-Year Monocentric Experience. Cancers (Basel). 2021;13(21)doi: 10.3390/cancers13215366.
Touloupas, C., Faron, M., Hadoux, J., Deschamps, F., Roux, C., Ronot, M., Yevich, S., Joskin, J., Gelli, M., Barbé, R., Lamartina, L., Tissot, H., Scoazec, J. Y., Malka, D., Ducreux, M., Baudin, E., de Baère, T., & Tselikas, L. (2021). Long Term Efficacy and Assessment of Tumor Response of Transarterial Chemoembolization in Neuroendocrine Liver Metastases: A 15-Year Monocentric Experience. Cancers, 13(21), . https://doi.org/10.3390/cancers13215366
Touloupas, Caroline, et al. "Long Term Efficacy and Assessment of Tumor Response of Transarterial Chemoembolization in Neuroendocrine Liver Metastases: A 15-Year Monocentric Experience." Cancers vol. 13,21 (2021). doi: https://doi.org/10.3390/cancers13215366
Touloupas C, Faron M, Hadoux J, Deschamps F, Roux C, Ronot M, Yevich S, Joskin J, Gelli M, Barbé R, Lamartina L, Tissot H, Scoazec JY, Malka D, Ducreux M, Baudin E, de Baère T, Tselikas L. Long Term Efficacy and Assessment of Tumor Response of Transarterial Chemoembolization in Neuroendocrine Liver Metastases: A 15-Year Monocentric Experience. Cancers (Basel). 2021 Oct 26;13(21). doi: 10.3390/cancers13215366. PMID: 34771531; PMCID: PMC8582443.
Copy
Download .nbib